Vident Investment Advisory’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-50,123
| Closed | -$847K | – | 1275 |
|
|
2022
Q1 | $847K | Buy |
50,123
+8,355
| +20% | +$141K | 0.02% | 759 |
|
|
2021
Q4 | $898K | Buy |
41,768
+17,883
| +75% | +$384K | 0.02% | 749 |
|
|
2021
Q3 | $1.76M | Sell |
23,885
-1,706
| -7% | -$126K | 0.05% | 490 |
|
|
2021
Q2 | $1.4M | Buy |
25,591
+11,020
| +76% | +$602K | 0.04% | 550 |
|
|
2021
Q1 | $1.07M | Hold |
14,571
| – | – | 0.04% | 592 |
|
|
2020
Q4 | $1.26M | Buy |
+14,571
| New | +$1.26M | 0.05% | 474 |
|